{
    "medicine_id": "e3b4a4d3269b5dc4e80836c278694bea6aa8642a",
    "platform_id": "DB11796",
    "metadata": {
        "name": "Rukobia 600 mg 1 Tablet film coated extended release",
        "composition": "600 mg 1 Fostemsavir",
        "clinical_particulars": {
            "therapeutic_indications": "Fostemsavir is indicated in combination with other antiretrovirals for the treatment of multidrug resistant HIV 1 infection in heavily treatment experienced adults failing their current antiretroviral therapy due to resistance intolerance or safety concerns L14867",
            "contraindications": {
                "disease": "Data regarding fostemsavir overdose are unavailable L14867 Symptoms of overdose are likely to be consistent with fostemsavir s adverse effect profile and may therefore involve significant GI disturbance and prolongation of the QT interval L14867 In the event of overdose patients should be monitored closely including the use of ECG and treated symptomatically as clinically indicated As fostemsavir is highly protein bound dialysis is unlikely to be of benefit in the event of an overdose L14867",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Temsavir inhibits the first stage in the HIV 1 viral lifecycle attachment L14867 It has a moderate duration of action necessitating twice daily dosing L14867 Fostemsavir administered at roughly 4x the recommended human dose has been observed to significantly prolong the QTc interval Patients with a history of QTc prolongation those receiving other QTc prolonging medications and or those with pre existing cardiac disease should use fostemsavir with caution and should be monitored at baseline and throughout therapy for signs or symptoms suggestive of QTc prolongation L14867 Fostemsavir should also be used with caution in patients with hepatitis B or C co infection as elevations in hepatic transaminases were observed in greater proportions in these populations in clinical trials L14867",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The serum concentration of Eluxadoline can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Delamanid"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Vemurafenib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Pitolisant can be decreased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "Caffeine may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Nelfinavir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Gefitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "Omeprazole may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "Beclomethasone dipropionate may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "Sorafenib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "Lansoprazole may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Telmisartan may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01051",
                        "description": "Novobiocin may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "Hesperetin may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Dasatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "Sunitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "Genistein may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02115",
                        "description": "Daidzin may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "Fusidic acid may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03467",
                        "description": "Naringenin may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "Quercetin may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "Taurocholic acid may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "Elacridar may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "Dovitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "Eltrombopag may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "Simeprevir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "Cabazitaxel may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "Vismodegib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Rilpivirine may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "Teriflunomide may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "Regorafenib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "Ponatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Dabrafenib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "Afatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Cannabidiol may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "Palbociclib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "Olaparib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "Daclatasvir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "Dasabuvir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "Rolapitant may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "Paritaprevir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "Alectinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "Venetoclax may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "Velpatasvir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "Istradefylline may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Fostemsavir may decrease the excretion rate of Folic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "Fostemsavir may decrease the excretion rate of Cladribine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Fostemsavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Fostemsavir may decrease the excretion rate of Allopurinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Fostemsavir may decrease the excretion rate of Teniposide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Fostemsavir may decrease the excretion rate of Prazosin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "Fostemsavir may decrease the excretion rate of Raloxifene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Fostemsavir may decrease the excretion rate of Celecoxib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "Fostemsavir may decrease the excretion rate of Zidovudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Fostemsavir may decrease the excretion rate of Vincristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Fostemsavir may decrease the excretion rate of Methotrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "Fostemsavir may decrease the excretion rate of Ivermectin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Fostemsavir may decrease the excretion rate of Testosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Fostemsavir may decrease the excretion rate of Clofarabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Fostemsavir may decrease the excretion rate of Sumatriptan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "Fostemsavir may decrease the excretion rate of Tamoxifen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Fostemsavir may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "Fostemsavir may decrease the excretion rate of Daunorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Fostemsavir may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Fostemsavir may decrease the excretion rate of Lamivudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "Fostemsavir may decrease the excretion rate of Riluzole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "Fostemsavir may decrease the excretion rate of Irinotecan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "Fostemsavir may decrease the excretion rate of Etoposide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "Fostemsavir may decrease the excretion rate of Donepezil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "Fostemsavir may decrease the excretion rate of Dactinomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00973",
                        "description": "Fostemsavir may decrease the excretion rate of Ezetimibe which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "Fostemsavir may decrease the excretion rate of Doxorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Fostemsavir may decrease the excretion rate of Glyburide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Fostemsavir may decrease the excretion rate of Topotecan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "Fostemsavir may decrease the excretion rate of Tegaserod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "Fostemsavir may decrease the excretion rate of Leflunomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "Fostemsavir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03496",
                        "description": "Fostemsavir may decrease the excretion rate of Alvocidib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04690",
                        "description": "Fostemsavir may decrease the excretion rate of Camptothecin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Fostemsavir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "Fostemsavir may decrease the excretion rate of Apixaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Fostemsavir may decrease the excretion rate of Pralatrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "Fostemsavir may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Fostemsavir may decrease the excretion rate of Riociguat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Fostemsavir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "Fostemsavir may decrease the excretion rate of Idelalisib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "Fostemsavir may decrease the excretion rate of Fimasartan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "Fostemsavir may decrease the excretion rate of Ombitasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Fostemsavir may decrease the excretion rate of Tenofovir alafenamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "Fostemsavir may decrease the excretion rate of Osimertinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "Fostemsavir may decrease the excretion rate of Selumetinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "Fostemsavir may decrease the excretion rate of Talazoparib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Fostemsavir may decrease the excretion rate of Ertugliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Fostemsavir may decrease the excretion rate of Delafloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "Fostemsavir may decrease the excretion rate of Duvelisib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "Fostemsavir may decrease the excretion rate of Dacomitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "Fostemsavir may decrease the excretion rate of Abemaciclib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "Fostemsavir may decrease the excretion rate of Brigatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "Fostemsavir may decrease the excretion rate of Rucaparib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "Fostemsavir may decrease the excretion rate of Copanlisib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "Fostemsavir may decrease the excretion rate of Tazemetostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "Fostemsavir may decrease the excretion rate of Lusutrombopag which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "Fostemsavir may decrease the excretion rate of Enasidenib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "Fostemsavir may decrease the excretion rate of Pibrentasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "Fostemsavir may decrease the excretion rate of Glecaprevir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Fostemsavir may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Fostemsavir may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Fostemsavir may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "Fostemsavir may decrease the excretion rate of Ripretinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Baricitinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "Avatrombopag may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "Fostamatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "Letermovir may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "Fedratinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Estradiol dienanthate may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "Medical Cannabis may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "Nabiximols may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "Fostemsavir may decrease the excretion rate of Pralsetinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Vardenafil"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Lomitapide"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Elagolix"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The excretion of Valsartan can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The excretion of Torasemide can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The excretion of Liothyronine can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00520",
                        "description": "The excretion of Caspofungin can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The excretion of Bosentan can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The excretion of Enalapril can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The excretion of Penicillamine can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The excretion of Repaglinide can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00917",
                        "description": "The excretion of Dinoprostone can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01053",
                        "description": "The excretion of Benzylpenicillin can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The excretion of Ouabain can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The excretion of Liotrix can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The excretion of Cholic Acid can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06199",
                        "description": "The excretion of Atrasentan can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06721",
                        "description": "The excretion of Gimatecan can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The excretion of Temocapril can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08862",
                        "description": "The excretion of Cholecystokinin can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08884",
                        "description": "The excretion of Gadoxetic acid can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "The excretion of Technetium Tc 99m mebrofenin can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The excretion of Levosalbutamol can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB04540",
                        "description": "Cholesterol may increase the excretion rate of Fostemsavir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Fostemsavir can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The excretion of Paclitaxel can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The excretion of Docetaxel can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB09142",
                        "description": "The excretion of Sincalide can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11936",
                        "description": "The excretion of Bempedoic acid can be decreased when combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Fostemsavir may decrease the excretion rate of Revefenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Cobimetinib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Vinblastine can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Cabergoline can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Fexofenadine can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Silodosin"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Tolvaptan"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Odanacatib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Edoxaban"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Technetium Tc 99m sestamibi"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Tezacaftor"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The serum concentration of Lefamulin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Tenofovir can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Prednisolone phosphate can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The serum concentration of Alpelisib can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11644",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Tafamidis"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "Fostemsavir may decrease the excretion rate of Ozanimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Fostemsavir may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00896",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Rimexolone"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Voxilaprevir can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The serum concentration of Ethinylestradiol can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Pravastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The serum concentration of Lovastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The serum concentration of Cerivastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The serum concentration of Atorvastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The serum concentration of Fluvastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The serum concentration of Rosuvastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB06693",
                        "description": "The serum concentration of Mevastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The serum concentration of Pitavastatin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Fostemsavir can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Fostemsavir"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}